April 30 (Reuters) - The U.S. Food and Drug
Administration has approved Johnson & Johnson's ( JNJ ) drug to
treat patients aged 12 years and older with an immune-mediated
disorder, the drugmaker said on Wednesday.
(Reporting by Mariam Sunny in Bengaluru)